- Fiat Chrysler CEO Marchionne Possibly on Prowl for a Deal With GM
- It's Time for the Eurozone to Let Greece and Tsipras Go
- How Casinos Failed Atlantic City and Why They're Still Part of Its Future
- $15 Minimum Wage Protests Could Spell Major Problem for Retailers
- Five Biggest Losers If LaGuardia Airport Drops Its Perimeter Rule
Central nervous system disorder specialist Chelsea Therapeutics International on Thursday said it had signed up to a bid from Denmark's H. Lundbeck that values its stock at up to $658 million.